Biblio
“Association between Coffee Consumption and Incident Risk of Disabling Dementia in Elderly Japanese: The Ohsaki Cohort 2006 Study.”, J Alzheimers Dis, vol. 50, no. 2, pp. 491-500, 2016.
, “Pain Assessment in Elderly with Behavioral and Psychological Symptoms of Dementia.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1217-25, 2016.
, “Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study.”, J Alzheimers Dis, vol. 51, no. 1, pp. 15-9, 2016.
, “Vitamin D and Memory Decline: Two Population-Based Prospective Studies.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1099-108, 2016.
, “Course and Determinants of Anosognosia in Alzheimer's Disease: A 12-Month Follow-up.”, J Alzheimers Dis, vol. 51, no. 2, pp. 357-66, 2016.
, “The Disconnection Hypothesis in Alzheimer's Disease Studied Through Multimodal Magnetic Resonance Imaging: Structural, Perfusion, and Diffusion Tensor Imaging.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1051-64, 2016.
, “Performance on Specific Cognitive Domains and Cause of Death: A Prospective Population-Based Study in Non-Demented Older Adults (NEDICES).”, J Alzheimers Dis, vol. 51, no. 2, pp. 533-44, 2016.
, “Associations between Serum Omega-3 Fatty Acid Levels and Cognitive Functions among Community-Dwelling Octogenarians in Okinawa, Japan: The KOCOA Study.”, J Alzheimers Dis, vol. 51, no. 3, pp. 857-66, 2016.
, “Specific Features of Subjective Cognitive Decline Predict Faster Conversion to Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 52, no. 1, pp. 271-81, 2016.
, “Associations between Use of Specific Analgesics and Concentrations of Amyloid-β 42 or Phospho-Tau in Regions of Human Cerebral Cortex.”, J Alzheimers Dis, vol. 61, no. 2, pp. 653-662, 2018.
, “The Diagnostic and Prognostic Value of a Dual-Tasking Paradigm in a Memory Clinic.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1189-1199, 2018.
, “Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1107-1117, 2018.
, “Vestibular Loss Predicts Poorer Spatial Cognition in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 3, pp. 995-1003, 2018.
, “White Matter Hyperintensity Predicts the Risk of Incident Cognitive Decline in Community Dwelling Elderly.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1333-1341, 2018.
, “Dilated Perivascular Spaces in the Centrum Semiovale Begin to Develop in Middle Age.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1619-1626, 2018.
, “Longitudinal Changes in Serum Glucose Levels are Associated with Metabolic Changes in Alzheimer's Disease Related Brain Regions.”, J Alzheimers Dis, vol. 62, no. 2, pp. 833-840, 2018.
, “Interactions between Atrial Fibrillation, Cardiovascular Risk Factors, and ApoE Genotype in Promoting Cognitive Decline in Patients with Alzheimer's Disease: A Prospective Cohort Study.”, J Alzheimers Dis, vol. 62, no. 2, pp. 713-725, 2018.
, “Deep Brain Stimulation of Frontal Lobe Networks to Treat Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 2, pp. 621-633, 2018.
, “Burden of Insomnia and Sleep Disturbances and the Impact of Sleep Treatments in Patients with Probable or Possible Alzheimer's Disease: A Structured Literature Review.”, J Alzheimers Dis, vol. 86, no. 1, pp. 83-109, 2022.
, “Antihypertensive Medication Class and the Risk of Dementia and Cognitive Decline in Older Adults: A Secondary Analysis of the Prospective HELIAD Cohort.”, J Alzheimers Dis, vol. 89, no. 2, pp. 709-719, 2022.
, “Neuroprotective Effect of Phloretin in Rotenone-Induced Mice Model of Parkinson's Disease: Modulating mTOR-NRF2-p62 Mediated Autophagy-Oxidative Stress Crosstalk.”, J Alzheimers Dis, vol. 94, no. s1, pp. S109-S124, 2023.
, “Diet's Role in Modifying Risk of Alzheimer's Disease: History and Present Understanding.”, J Alzheimers Dis, vol. 96, no. 4, pp. 1353-1382, 2023.
, “Cycloheximide Treatment Causes a ZVAD-Sensitive Protease-Dependent Cleavage of Human Tau in Drosophila Cells.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1161-8, 2016.
, “Dimethyl Fumarate is a Potential Therapeutic Option for Alzheimer's Disease.”, J Alzheimers Dis, vol. 85, no. 1, pp. 443-456, 2022.
, “The Effects of Latrepirdine on Amyloid-β Aggregation and Toxicity.”, J Alzheimers Dis, vol. 50, no. 3, pp. 895-905, 2016.
,